|
by Marchand, Dave K., Loshak, Hannah
Published 2019
Subjects:
“...Canada...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Marchand, Dave K., Argáez, Charlene
Published 2020
Subjects:
“...Canada...”Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Marchand, Dave K., McCormack, Suzanne
Published 2019
Subjects:
“...Canada...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Marchand, Dave K., Farrah, Kelly
Published 2019
Subjects:
“...Canada...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Marchand, Dave K., McCormack, Suzanne
Published 2020
Subjects:
“...Canada...”Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Marchand, Dave K., Farrah, Kelly
Published 2019
“..., in order to restore blood flow. In Canada, the thrombolytics alteplase and tenecteplase are currently...”Published 2019
Canadian Agency for Drugs and Technologies in Health